Companies › NSPR
INSPIREMD INC (NSPR)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001433607 · EDGAR filings · Updated 2026-07-23
INSPIREMD INC (NSPR) has reported institutional ownership of 48.7%, with 35 institutional managers holding positions valued at $37.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-23 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-02 — Current report (8-K) filed
- 2026-06-11 — Current report (8-K) filed
- 2026-06-03 — Current report (8-K) filed
- 2026-05-29 — Insider transaction reported (Form 4)
- 2026-05-22 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, INSPIREMD INC has 35 institutional holders and institutional ownership of 48.7%.
Insider activity
Insiders reported 36 transactions (9 buys, 10 sells) across 12 reporting insiders, with a net reported value of $214.8K.
Data flags from SEC filings
Related companies
TENAYA THERAPEUTICS INC (TNYA) · Cardiol Therapeutics Inc (CRDL) · BIOMEA FUSION INC (BMEA) · iBio Inc (IBIO) · PROTALIX BIOTHERAPEUTICS INC (PLX) · SEER INC (SEER)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.